Atlas Trials

A Real-world Study to Evaluate the Safety and Immunogenicity of a Third-dose Booster After Two Doses of an Inactivated COVID-19 Vaccine

Clinical trial NCT05493917 · UNKNOWN

Trial details

NCT number
NCT05493917
Sponsor
Huashan Hospital
Status
UNKNOWN
Study type
OBSERVATIONAL
COVID-19Vaccine Reaction
Start date
2021-11-03
Primary completion
2022-12-31
Enrollment
2000

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.